KarXT
CN012-0045
Phase 3 small_molecule active
Quick answer
KarXT for Irritability Associated With Autism Spectrum Disorder is a Phase 3 program (small_molecule) at Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bristol-Myers Squibb
- Indication
- Irritability Associated With Autism Spectrum Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active